Opioid Receptor μ-1 and Ketamine Effects in a Suicidal Depression Trial: A Post Hoc Exploration

J Clin Psychopharmacol. 2020 Jul/Aug;40(4):420-422. doi: 10.1097/JCP.0000000000001237.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Administration, Intravenous
  • Depressive Disorder, Major / drug therapy*
  • Depressive Disorder, Major / genetics
  • Genotype
  • Humans
  • Ketamine / administration & dosage
  • Ketamine / therapeutic use*
  • Midazolam / therapeutic use
  • Polymorphism, Single Nucleotide / genetics
  • Receptors, Opioid, mu / genetics*
  • Suicidal Ideation*

Substances

  • OPRM1 protein, human
  • Receptors, Opioid, mu
  • Ketamine
  • Midazolam